Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2017-2027

Global Vaccine Contract Manufacturing Market Report 2017-2027

Leading Countries, Technologies and Companies

PUBLISHED: 23 February 2017
PAGES: 154
PRODUCT CODE: PHA0172

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0172 Categories: , ,

The global vaccine contract manufacturing market is expected to grow at a CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. The market is expected to grow at a CAGR of 9.1% from 2016 to 2027. The market is estimated at $816m in 2016, and $2117m in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 74 charts – all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Vaccine Contract Manufacturing Market Report 2017-2027

Report Scope
• Revenue and growth forecasts to 2027 for the global vaccine market and market shares of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines

• Revenue and growth forecasts to 2027 for the global vaccine contract manufacturing market

• Revenue and growth forecasts to 2027 for the leading national markets:
– United States
– Germany
– France
– United Kingdom
– Italy
– Spain
– Japan
– Brazil
– Russia
– China
– India
– Rest of the World

• Revenue and growth forecasts to 2027 for the leading players in the vaccine contract manufacturing market:
– Baxter BioPharma Solutions
– Boehringer Ingelheim
– Catalent
– Charles River Laboratories
– IDT Biologika
– Lonza
– Meridian Life Science
– Sigma Aldrich Fine Chemicals
– Merck
– Synco Bio Partners

• Analysis of what stimulates and restrains the global vaccine contract manufacturing market

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2017-2027: Leading Countries, Technologies and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2017-2027


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ